What is Soranib 200 mg Tablet?
Soranib is a cancer (chemotherapeutic) medication. Soranib, manufactured by Cipla, contains Sorafenib Tosylate as an active ingredient. soranib 200mg is a prescription oncology drug that should be used under proper medical guidance and advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug.
Soranib 200 mg Tablets Uses :
Soranib (Sorafenib) is an oral medication which is used in the treatment of liver, kidney or thyroid cancer called :
Hepatocellular carcinoma (HCC, a type of liver cancer) – Hepatocellular carcinoma (HCC) is a primary malignancy of the liver and occurs predominantly in patients with underlying chronic liver disease and cirrhosis.
Renal cell carcinoma (RCC, a type of kidney cancer) – Renal cell cancer is a disease in which malignant (cancer) cells are found in the lining of tubules (very small tubes) in the kidney.
Differentiated thyroid carcinoma (DTC, a type of thyroid cancer) – It is a cancer that starts in the thyroid gland. The thyroid is a gland that is at the base of your neck, just behind the small hollow where you collar bones meet.
Soranib Sorafenib 200 mg Tablets Work :
Sorafenib is a type of biological therapy called a protein tyrosine kinase inhibitor (TKI). Tyrosine kinase is a protein which acts as a chemical messenger (an enzyme). There are a number of different tyrosine kinases that encourage cancer cells to grow.
Sorafenib blocks some of the protein kinases and is called a multi kinase inhibitor. It works in two ways. soranib 200mg uses to helps block tumors from forming new blood vessels, which they need to grow. It also targets some of the proteins on cancer cells that normally help them grow.
Mechanism of Action
The drug is a kinase inhibitor and it decreases the number of tumour cell proliferation in the body.sorafenib 200 mg dosage was shown to inhibit more than one intracellular (BRAF, c-CRAF, and mutant BRAF) kinesis. It was shown to inhibit more than one cell surface kinesis. Researchers are of the opinion that many of this kinesis are involved in tumour cell signaling, apoptosis, and angiogenesis. Sorafenib slowed down tumour growth of RCC, HCC, and DTC human tumor xenografts in immune-compromised mice. Sorafenib treatment caused reductions in tumor angiogenesis in models of RCC and HCC.
Soranib 200 mg tablet Side Effects
Some of the common soranib 200mg side effects include:
- mouth sores
- coughing up blood or vomit
- black, bloody, or tarry stools
- pale skin,
- feeling short of breath
- rapid heart rate,
- trouble concentrating
- easy bruising,
- unusual bleeding (nose, mouth, vagina, or rectum),
- chest pain or heavy feeling,
Observations reveal that Sorafenib treatment caused an increase in tumor apoptosis in models of RCC, HCC, and DT
Soranib 200 mg – Storage Details :
Patients must properly store the drug to retain its quality and efficacy. Following storage instructions will be helpful in storing soranib 200mg in the best of manner.
Store Sorafenib at 25°C (77°F); excursions are permitted between 15°C and 30°C (59°F and 86°F).
Store it in a cool, dry place, away from direct heat and light.
Keep this and all medicines out of the reach of children and pets. A locked cupboard at least one-and-a-half meters above the ground is a good place to store medicines.
For More Information Visite Our Site :Strapcart.com